Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Itraconazole market size was valued at USD 627.28 Million in 2022 and will reach USD 705.59 Million in 2028, with a CAGR of 1.98% during 2022-2028.
Itraconazole is a triazole class of high-efficiency broad-spectrum antifungal drugs, which can combine with fungal cytochrome P450 isoenzymes to inhibit the synthesis of ergosterol. Itraconazole against Dermatophytes, Candida, Cryptococcus neoformans, Pityrosporum, Aspergillus, Histoplasma, Paracoccus brasiliensis, Sporothrix Schenckii, Color fungi, Cladosporium It is effective for infections such as molds and dermatitis blastomycetes.
Risks from the COVID-19 outbreak
Currently, the COVID-19 virus is still spreading around the world. Although the global economy is gradually recovering, the uncertainty of the epidemic has brought uncertainty to the development of various industries around the world. The development of the industry depends to a certain extent on the strength of local epidemic prevention and control measures. This also includes this industry.
In general, COVID-19 has led to a decline in management efficiency of itraconazole companies, obstructed commuting, obstructed production plans, reduced physical offline sales, and reduced company revenue. For example, in the first quarter of 2020, China's pharmaceutical manufacturing industry was affected by the outbreak of the new crown epidemic. Pharmaceutical companies have delayed the start of work to varying degrees, suspension of production, transportation obstruction, logistics control, and personnel traffic restrictions have had a significant impact on the business of pharmaceutical companies. Especially for some weak enterprises, they will even face the risk of breaking the capital chain and going bankrupt in the short term.
At the same time, the outbreak of the COVID-19 virus has also promoted the expansion of online pharmacies. Customers are now increasingly expecting express delivery and delivery speed, which means retailers need to maintain more inventory. In many cases, storage capacity has not grown exponentially. For manufacturers, manufacturing equipment needs to be more flexible than before. This puts pressure on enterprises to a certain extent.
Side effects of itraconazole
Itraconazole prescription drugs can cause side effects when used. Among them, itraconazole is associated with severe liver toxicity, including liver failure and death. Some of these cases have neither pre-existing liver disease nor serious underlying disease. In addition, the possible side effects of using itraconazole include nausea, abdominal pain, vomiting, fatigue, rash, diarrhea, and discomfort. Itraconazole drugs can interact with other drugs, so be careful when using it at the same time with other drugs. The side effects of these products are restricting the continuous development of the industry.
Invasive fungal infection, a high-risk disease whose incidence is increasing year by year
For the Itraconazole industry, the rise in cases of invasive fungal infections is one of the factors driving the development of the industry. In recent years, the incidence of invasive and opportunistic fungal diseases has increased significantly. Such as the increase in Candida infections in Europe. This fungus is easily spread in the healthcare environment, can cause invasive infections, and is also related to resistance to many antifungal drugs. For example, in Germany, Candida yeast is the most common pathogen causing invasive fungal infections. According to the German Krankenhaus-Infektions-Surveillance-System (KISS) data, 6.5% of bloodstream infections in intensive care units are caused by this pathogen.
Region Overview:
In global comparison, a significant portion of the revenue was generated in Asia Pacific (51.71% in 2021).
Company Overview:
Janssen Pharmaceutica is one of the major players operating in the Itraconazole market, holding a share of 12.31% in 2022.
Janssen Pharmaceutica
Janssen Pharmaceutica is a pharmaceutical company of Johnson & Johnson. Through the use of science to overcome diseases, use ingenuity to improve access, and use the soul to heal despair, it makes unremitting efforts to create the future for patients all over the world. Janssen Pharmaceutica focuses on the medical fields that can play the most role: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience, oncology, and pulmonary hypertension.
Mylan
Mylan is a generic medicine, specialty medicine, and API production company. The company was founded in the United States and registered in the Netherlands. Its operating headquarters is in Hatfield, Hertfordshire, UK.
Segmentation Overview:
By type, Capsule segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Hospital segment occupied the biggest share from 2017 to 2022.
The Itraconazole market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Itraconazole market covered in Chapter 4:
Tianjin Lisheng Pharmaceutical
Brilliant Pharmaceutical Co. Ltd.
Honz Pharmaceutical
Mankind Pharma
Macleods
Harbin Medisan
Janssen Pharmaceutica
Le Pu Pharmaceutical
Mylan
In Chapter 12 and Chapter 14.1, on the basis of types, the Itraconazole market from 2018 to 2028 is primarily split into:
Capsule
Cream
Tablet
Injection
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Itraconazole market from 2018 to 2028 covers:
Hospital
Pharmacy
Clinics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Itraconazole market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Itraconazole market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Itraconazole industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Itraconazole industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Itraconazole market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Itraconazole market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Itraconazole market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Itraconazole market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2022
Itraconazole is a triazole class of high-efficiency broad-spectrum antifungal drugs, which can combine with fungal cytochrome P450 isoenzymes to inhibit the synthesis of ergosterol. Itraconazole against Dermatophytes, Candida, Cryptococcus neoformans, Pityrosporum, Aspergillus, Histoplasma, Paracoccus brasiliensis, Sporothrix Schenckii, Color fungi, Cladosporium It is effective for infections such as molds and dermatitis blastomycetes.
Risks from the COVID-19 outbreak
Currently, the COVID-19 virus is still spreading around the world. Although the global economy is gradually recovering, the uncertainty of the epidemic has brought uncertainty to the development of various industries around the world. The development of the industry depends to a certain extent on the strength of local epidemic prevention and control measures. This also includes this industry.
In general, COVID-19 has led to a decline in management efficiency of itraconazole companies, obstructed commuting, obstructed production plans, reduced physical offline sales, and reduced company revenue. For example, in the first quarter of 2020, China's pharmaceutical manufacturing industry was affected by the outbreak of the new crown epidemic. Pharmaceutical companies have delayed the start of work to varying degrees, suspension of production, transportation obstruction, logistics control, and personnel traffic restrictions have had a significant impact on the business of pharmaceutical companies. Especially for some weak enterprises, they will even face the risk of breaking the capital chain and going bankrupt in the short term.
At the same time, the outbreak of the COVID-19 virus has also promoted the expansion of online pharmacies. Customers are now increasingly expecting express delivery and delivery speed, which means retailers need to maintain more inventory. In many cases, storage capacity has not grown exponentially. For manufacturers, manufacturing equipment needs to be more flexible than before. This puts pressure on enterprises to a certain extent.
Side effects of itraconazole
Itraconazole prescription drugs can cause side effects when used. Among them, itraconazole is associated with severe liver toxicity, including liver failure and death. Some of these cases have neither pre-existing liver disease nor serious underlying disease. In addition, the possible side effects of using itraconazole include nausea, abdominal pain, vomiting, fatigue, rash, diarrhea, and discomfort. Itraconazole drugs can interact with other drugs, so be careful when using it at the same time with other drugs. The side effects of these products are restricting the continuous development of the industry.
Invasive fungal infection, a high-risk disease whose incidence is increasing year by year
For the Itraconazole industry, the rise in cases of invasive fungal infections is one of the factors driving the development of the industry. In recent years, the incidence of invasive and opportunistic fungal diseases has increased significantly. Such as the increase in Candida infections in Europe. This fungus is easily spread in the healthcare environment, can cause invasive infections, and is also related to resistance to many antifungal drugs. For example, in Germany, Candida yeast is the most common pathogen causing invasive fungal infections. According to the German Krankenhaus-Infektions-Surveillance-System (KISS) data, 6.5% of bloodstream infections in intensive care units are caused by this pathogen.
Region Overview:
In global comparison, a significant portion of the revenue was generated in Asia Pacific (51.71% in 2021).
Company Overview:
Janssen Pharmaceutica is one of the major players operating in the Itraconazole market, holding a share of 12.31% in 2022.
Janssen Pharmaceutica
Janssen Pharmaceutica is a pharmaceutical company of Johnson & Johnson. Through the use of science to overcome diseases, use ingenuity to improve access, and use the soul to heal despair, it makes unremitting efforts to create the future for patients all over the world. Janssen Pharmaceutica focuses on the medical fields that can play the most role: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience, oncology, and pulmonary hypertension.
Mylan
Mylan is a generic medicine, specialty medicine, and API production company. The company was founded in the United States and registered in the Netherlands. Its operating headquarters is in Hatfield, Hertfordshire, UK.
Segmentation Overview:
By type, Capsule segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Hospital segment occupied the biggest share from 2017 to 2022.
The Itraconazole market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Itraconazole market covered in Chapter 4:
Tianjin Lisheng Pharmaceutical
Brilliant Pharmaceutical Co. Ltd.
Honz Pharmaceutical
Mankind Pharma
Macleods
Harbin Medisan
Janssen Pharmaceutica
Le Pu Pharmaceutical
Mylan
In Chapter 12 and Chapter 14.1, on the basis of types, the Itraconazole market from 2018 to 2028 is primarily split into:
Capsule
Cream
Tablet
Injection
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Itraconazole market from 2018 to 2028 covers:
Hospital
Pharmacy
Clinics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Itraconazole market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Itraconazole market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Itraconazole industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Itraconazole industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Itraconazole market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Itraconazole market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Itraconazole market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Itraconazole market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
